ChengDu ShengNuo BiotecLtd Past Earnings Performance
Past criteria checks 3/6
ChengDu ShengNuo BiotecLtd has been growing earnings at an average annual rate of 6.5%, while the Pharmaceuticals industry saw earnings growing at 9.2% annually. Revenues have been growing at an average rate of 4.5% per year. ChengDu ShengNuo BiotecLtd's return on equity is 8.1%, and it has net margins of 15.9%.
Key information
6.5%
Earnings growth rate
-2.5%
EPS growth rate
| Pharmaceuticals Industry Growth | 10.9% |
| Revenue growth rate | 4.5% |
| Return on equity | 8.1% |
| Net Margin | 15.9% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How ChengDu ShengNuo BiotecLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 458 | 73 | 159 | 34 |
| 31 Dec 23 | 435 | 70 | 161 | 29 |
| 30 Sep 23 | 427 | 60 | 177 | 25 |
| 30 Jun 23 | 402 | 66 | 169 | 20 |
| 31 Mar 23 | 396 | 64 | 164 | 23 |
| 31 Dec 22 | 396 | 64 | 160 | 23 |
| 30 Sep 22 | 368 | 57 | 146 | 24 |
| 30 Jun 22 | 360 | 56 | 154 | 22 |
| 31 Mar 22 | 374 | 64 | 170 | 14 |
| 31 Dec 21 | 387 | 61 | 192 | 14 |
| 30 Sep 21 | 387 | 61 | 207 | 15 |
| 30 Jun 21 | 397 | 53 | 230 | 19 |
| 31 Mar 21 | 401 | 62 | 227 | 20 |
| 31 Dec 20 | 379 | 60 | 214 | 18 |
| 31 Dec 19 | 327 | 48 | 192 | 11 |
| 31 Dec 18 | 278 | 30 | 143 | 16 |
| 31 Dec 17 | 194 | 34 | 72 | 14 |
Quality Earnings: 688117 has a high level of non-cash earnings.
Growing Profit Margin: 688117's current net profit margins (15.9%) are lower than last year (16.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688117's earnings have grown by 6.5% per year over the past 5 years.
Accelerating Growth: 688117's earnings growth over the past year (13.3%) exceeds its 5-year average (6.5% per year).
Earnings vs Industry: 688117 earnings growth over the past year (13.3%) exceeded the Pharmaceuticals industry -1.1%.
Return on Equity
High ROE: 688117's Return on Equity (8.1%) is considered low.